Publication Name	World Journal of Hepatology
Manuscript ID	13177
Country	Israel

Received	2014-08-09 21:05
Peer-Review Started	2014-08-11 08:16
To Make the First Decision	2014-08-28 15:05
Return for Revision	2014-08-30 17:19
Revised	2014-10-06 03:06
Second Decision	2014-12-26 08:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-12-31 13:19
Articles in Press	2014-12-31 13:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-20 12:16
Publish the Manuscript Online	2015-03-31 15:58

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
Manuscript Source	Invited Manuscript
All Author List	Liat Mlynarsky, Yoram Menachem and Oren Shibolet
Funding Agency and Grant Number
Corresponding Author	Oren Shibolet, MD, Director of the Liver Unit, Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Tel-Aviv University, 6 Weizman St. Tel-Aviv 64239, Israel. orensh@tasmc.health.gov.il
Key Words	Hepatocellular carcinoma; Liver resection; Liver transplantation; Loco-ablative therapies; Sorafenib
Core Tip	We chose to focus on the aspect of treatment modalities of hepatocellular carcinoma (HCC) and discuss the benefits and disadvantages of each modality. We report on the diversity of treatments and the allocation of patients with HCC to the different modalities according to the Barcelona-Clinic Liver Cancer. Moreover, we discuss novel treatments currently under investigation and not yet recommended by acceptable guidelines.
Publish Date	2015-03-31 15:58
Citation	Mlynarsky L, Menachem Y, Shibolet O. Treatment of hepatocellular carcinoma: Steps forward but still a long way to go. World J Hepatol 2015; 7(3): 566-574
URL	http://www.wjgnet.com/1948-5182/full/v7/i3/566.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i3.566

Full Article (PDF)	WJH-7-566.pdf
Full Article (Word)	WJH-7-566.doc
Manuscript File	13177-Review.docx
Answering Reviewers	13177-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13177-Conflict-of-interest statement.pdf
Copyright License Agreement	13177-Copyright assignment.pdf
Peer-review Report	13177-Peer review(s).pdf
Scientific Misconduct Check	13177-CrossCheck.jpg
Scientific Editor Work List	13177-Scientific editor work list.pdf